In this study, the South African Amaryllid Boophone haemanthoides was examined for its phytochemical composition and cytotoxicity. In the process eight alkaloid structures, including the new compound distichaminol, were identified in bulb ethanolic extracts. Of the isolates, lycorine and distichamine exhibited strong activities against human acute lymphoblastic leukemia (CEM), breast adenocarcinoma (MCF7) and cervical adenocarcinoma (HeLa) cells with IC 50 s ranging from 1.8 to 9.2 M.
Southern Africa is a center of prominence for the family Amaryllidaceae, containing roughly a third of the global population of around 1000 species [1] . Its members are known for their horticultural and ornamental appeal with significant impact on the floriculture sector [1] . More importantly, its medicinal properties have long been realized in the traditional medicinal practices of indigenous peoples across the globe [2] . For example, the discovery of galanthamine (1) (scheme 1) as an Alzheimer's drug evolved out of the ethnic usage of Galanthus species, from which the compound was first isolated, in the Caucasus region of Eastern Europe [3] . In South Africa the Amaryllidaceae has a long history of use for medicinal purposes amongst its indigenous people which can be traced back to its original inhabitants, the San [2a,b] .
The chemicals responsible for these medicinal attributes are alkaloids, structural variations of which are unique to the Amaryllidaceae [2] . Six different structural types are discernible for these compounds as represented by galanthamine (1) , lycorine (2), crinine (3), homolycorine (4), tazettine (5) and montanine (6) [2] . Other less conspicuous members include degraded, oxidized and truncated variants, such as trisphaeridine (7) and ismine (8) [2] . All of these compounds are related, as a consequence of their biogenesis, from a common amino acid derived precursor, norbelladine (9) [2] . The pharmaceutical value of the Amaryllidaceae is epitomized by the FDA approved status granted to galanthamine (1) due to its potent and selective inhibitory interaction with the enzyme acetylcholinesterase (AChE), of significance in the progression of neurodegeneration associated with motor neuron diseases [3] . Following on the commercial success of galanthamine as an Alzheimer's drug, it is anticipated that further clinical candidates will emerge out of the phenanthridones {such as pancratistatin (10)} of the lycorine (2) series of alkaloids, which are known for their potent and selective antiproliferative properties [4] . Not surprisingly, therefore, AChE inhibition and cytotoxicity are two recurrent themes in the pharmacology of Amaryllidaceae alkaloids [3, 4] .
Lycorine (2) (scheme 1) is the most common alkaloid across the Amaryllidaceae and known for a broad spectrum of biological properties, including antiviral [5a] , antifungal [5b], antiparasitic [5c] and anti-inflammatory [5d] activities, as well as antifeedant [5e], cell growth [5f] and AChE [5g] inhibitory effects. Furthermore, it has shown much promise as an antiproliferative agent capable of inhibiting cell division and cell elongation, as well as protein synthesis in eukaryotic cells [5h] . Its chemotherapeutic potential is best underlined by its antitumor effects in a number of cancer cell lines [6] . Furthermore, both in vitro and in vivo models of leukemia (HL-60) cells support the potency of lycorine as an anticancer agent [6d,e]. Notably, in some cell lines these effects were manifested via the apoptotic mechanistic pathway [6e-g]. In contrast, antiproliferative effects of lycorine were also exerted in apoptosis-resistant cell lines such as OE21 oesophageal cancer and SKMEL-28 melanoma cells [6h].
As mentioned above, the phenanthridone, pancratistatin (10), of the lycorine series has shown most promise for clinical development as an anticancer agent [7] . This potential is vindicated by the fact that pancratistatin selectively targeted mitochondria of cancer cells, with minimal effect on normal cells, initiating cell death via the apoptotic pathway, as indicated by early activation of caspase-3, followed by flipping of phosphatidyl serine [7e,f]. A stronger case could be made for commercial development of these targets based on their low interaction with the isoenzyme cytochrome P450 3A4, which is responsible for metabolism of the majority of drugs taken by humans [8] . By contrast, the crinane group, exemplified by crinine (3), is a broad and expanding group of compounds also known for diverse biological properties [9] .
Given their close structural similarity to the lycorine series of compounds [2], cytotoxic effects have been demonstrated for several members of the crinane group [9b]. Over the past two decades there has been significant interest in diverse research aspects of the Amaryllidaceae, including areas pertaining to its ethnobotany, phytochemistry and pharmacology [2] [3] [4] [5] [6] [7] [8] [9] . In addition, synthetic endeavors have targeted some of its bioactive constituents for structure-activity relationship (SAR) study purposes [4, 10] . In continuation of these efforts, the South African Amaryllid Boophone haemanthoides was here investigated for its alkaloid composition and cytotoxic effects against a mini-panel of cancer cells. Seven alkaloids of the -crinane series, including crinine (3), buphanisine (11), buphanidrine (12), ambelline (13), undulatine (14) , distichamine (16) and distichaminol (17), together with lycorine (2) (scheme 1) were isolated and identified by a combination of physical and spectroscopic methods. Cytotoxic effects were demonstrated for lycorine and distichamine in acute lymphoblastic leukemia (CEM), breast adenocarcinoma (MCF7) and cervical adenocarcinoma (HeLa) cells with IC 50 s determined in the range 1.8 to 9.2 M, while distichaminol (17) was uncovered as a novel alkaloid.
The African genus Boophone Herb. is comprised of two known species, B. disticha (L.f.) Herb. and B. haemanthoides F.M. Leight. B. disticha is widely distributed in Africa, ranging from Sudan in the north to the Western Cape Province in the south, while B. haemanthoides is a rare and threatened species with a restricted territory within the winter rainfall region of South Africa and parts of southern Namibia [11a] . Both plants are known to be widely used in traditional medicine [11b,c] . Isolation of the alkaloids from bulbs of B. haemanthoides is described in the Experimental section. Of the compounds isolated, lycorine (2), crinine (3), buphanisine (11), buphanidrine (12), ambelline (13) and undulatine (14) (scheme 1) are common across most genera of the Amaryllidaceae [2]. By contrast, distichamine (16) is unique in that its C-ring double bond is situated at C-2/C-3, as opposed to the usual C-1/C-2 positioning in most crinane compounds, with concomitant vinylization of the C-3 methoxyl group, as well as oxidation at C-1. Moreover, it has never been found outside the genus Boophone and as such occupies a privileged chemosystematic status within the Amaryllidaceae [11d]. A previous phytochemical study made on a wild population of B. haemanthoides from the Saldhana Bay area of South Africa revealed the presence of buphanidrine, buphanisine, crinine and distichamine [11d] . In the present study, bulbs of B. haemanthoides were collected in the Nieuwoudtville area of the Northern Cape Province of South Africa. The elucidation of the novel structure distichaminol (17) was based on its close structural similarity to distichamine (16) and buphanamine (21), previously described from B. disticha [12] . HRMS indicated a mass of 332.1491 g/mol for the [M+1] + ion of distichaminol, correct for the molecular formula C 18 H 22 NO 5 and theoretical mass 332.1498 g/mol. Furthermore, its EIMS had the molecular ion [M] + peak at m/z 331 with a relative abundance of 89%. Diagnostic fragment ions were detected at m/z 316 [M-CH 3 ] + , 299 [M-CH 3 OH] + and 281 [M-CH 3 OH-H 2 O] + . FTIR indicated inter alia the presence of hydroxyl (3500-3000 cm -1 ), aryl (1617 cm -1 ), methoxyl (1039 cm -1 ) and methylenedioxy (934 cm -1 ) groups.
The 1 H and 13 CNMR spectra of distichaminol (17) were similar to those of distichamine (16) and only differences due to the C-1 hydroxyl group in 17 were significant (Table 1) respectively. The corresponding carbon resonances were detected at  100.6 (d, C-10), 100.9 (t, OCH 2 O), 96.8 (d, C-2) and 72.2 (d, C-1) respectively, as determined by HSQC experiments (Table 1) . Two Table 1 : 1D and 2D NMR spectroscopic data for distichaminol (17).
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and three bond HMBC correlations linked H-10 to C-6a, C-8, C-9, C-10a and C-10b. The C-1 carbon resonance, indicative of a hydroxy-substituted allylic methine carbon in 17, is distinguished from that of distichamine (16) (21) [12b]. In addition, allylic coupling was established via COSY between H-2 and the methylene protons H-4 and H-4 by the small value of the coupling between them (J=1.0 Hz).
The oxygen and nitrogen related proton signals were resonant in the  2.6-4.2 region, of which the diastereotropic C-6 protons were immediately apparent based on their chemical shift, multiplicity and coupling constants. As such, H-6 ( 4.14, d, J=17.3 Hz) was shifted further downfield than H-6 ( 3.79, d, J=17.3 Hz) due to the former being cis-disposed to the nitrogen atom (Table 1 ). This was also true for H-12exo ( 3.45, ddd, J=12.9, 10.0, 3.8 Hz) resonating further downfield to H-12endo ( 2.76, ddd, J=12.9, 9.0, 5.6 Hz). HSQC analysis showed these protons to be attached to methylene carbons which resonated at  57.8 (t, C-6) and 51.3 (t, C-12), respectively. The remaining three-proton singlet resonance signals in this region were ascribable to the vinyl C-3 ( 3.57) and aryl C-7 ( 3.97) methoxy groups, while the nitrogen related methine proton H-4a was resonant at  3.26 (dd, J=10.0, 7.0 Hz). As expected, the methylene protons at C-4 and C-11 were the most shielded. An anti-periplanar relationship between H-4a and H-4 was established by the large value of the coupling between them (J=10.0 Hz). All eighteen carbons of distichaminol (17) were accounted for by 13 C and HSQC NMR and multiplicities ascertained by DEPT analysis (Table 1 ). Furthermore, absolute configuration of the 5,10b-ethano-bridge was arrived at by circular dichroism (CD) measurements which showed that distichaminol was qualitatively similar to -5,10b-ethanophenanthridine compounds with a maximum at 250 nm and a minimum at 286 nm in its CD curve [13] .
A mini-panel of cancer cells comprising CEM, MCF7 and HeLa cells, as well as the normal human fibroblast (BJ) cell line was engaged for the cytotoxicity screen using staurosporine and galanthamine as positive and negative controls, respectively. As determined by the Calcein AM assay [14] , lycorine (2) decreased the survival of all three cancer cell lines in a dose-dependent manner after 72 h treatments, with IC 50 values of 1.8, 9.2 and 8.9 µM, respectively (Table 2 ). This result is not surprising given that the cytotoxic properties of lycorine have been widely studied [6] . Similarly, distichamine (16) was noticeably active, exhibiting IC 50 s of 5.1, 2.3 and 4.0 µM against the three cancer cells respectively, in accordance with a previous report [14] . However, both lycorine and distichamine were not selective in their activity since normal BJ cells were also affected to a significant extent by the treatment (IC 50 2.0 and 12.4 M, respectively), in agreement with earlier findings [6, 14] . Furthermore, the -crinane compounds crinine (3), buphanisine (11), buphanidrine (12) and ambelline (13), all of which possess a C-1/C-2 double bond, as well as polar substitution at C-3, were inactive against both normal and cancerous cells (IC 50 s > 50 M). This was also the case for the 1,2--epoxide undulatine (14) , as well as the new compound distichaminol (17) (IC 50 s > 50 M against both normal and cancer cell types).
Since the identification of haemanthamine (19) (16), capable of inducing caspase-3 activated apoptosis in CEM cells, has recently been described [14] .
Essential features of the crinane alkaloid cytotoxic pharmacophore which have come to the fore from these studies may be summarized as follows: i) the modulatory effect of the C-ring double bond (as seen in crinamine and crinine compared with their respective dihydro-analogues [15] , as well as in distichamine in which the double bond features at C-2/C-3) [14] ; ii) the effect of polar substitution at C-3, indicating that a H-bond acceptor is required at this position (as shown for crinamine, haemanthamine and distichamine, in possession of -, and planar methoxy groups at C-3, respectively) [14, 15] ; iii) presence of a small substituent at C-11 (H or OH), the function of which does not appear to involve hydrogen bonding but is subject to steric constraints alone (evident for crinine, crinamine, haemanthamine and distichamine) [14, 15] ; and iv) oxidation at C-1 appears to be pivotal to activity {as in distichamine (16)} [14] . Furthermore, reversal of the polarity of the C-1 center in accommodating a hydroxyl group (as in distichaminol 17) is here shown to be detrimental.
In summary, phytochemical investigation of the rare and threatened southern African Amaryllid Boophone haemanthoides has led to the identification of lycorine together with seven members of the crinane series, of which distichaminol was uncovered as a novel compound. This compound is unique within the crinane series of Amaryllidaceae alkaloids in that its C-ring double bond is situated in the unusual C-2/C-3 position (as opposed to the usual C-1/C-2 position), thus accommodating the C-1 hydroxyl as well as the C-3 vinylic methoxyl groups. It is only the second member of the crinane alkaloids identified with such a substitution, the other being distichamine. Distichaminol was shown to be non-toxic to both cancer and normal cells, which contributes further to the understanding of the pharmacophoric requirements for cytotoxic activity as well as apoptosis induction within the crinane series of Amaryllidaceae alkaloids. (14), 207 (100), 191 (16), 179 (7), 165 (19), 135 (19), 115 (34) .
Cytotoxicity bioassays
Cell cultures: Stock solutions (10 mmol/L) of test compounds were prepared in dimethylsulfoxide (DMSO). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), L-glutamine, penicillin and streptomycin were purchased from Sigma (MO, USA). Calcein AM was obtained from Molecular Probes (Invitrogen Corporation, CA, USA). Test cell lines comprising T-lymphoblastic leukemia CEM, breast carcinoma MCF7, cervical carcinoma HeLa and human fibroblasts BJ were obtained from the American Type Culture Collection (Manassas, VA, USA). All cell lines were cultured in DMEM medium (Sigma, MO, USA), supplemented with 10% heat-inactivated fetal bovine serum, 2 mmol/L L-glutamine, 10,000U penicillin and 10 mg/mL streptomycin. Cell lines were maintained under standard cell culture conditions (37ºC and 5% CO 2 in a humid environment), and were sub-cultured twice or thrice weekly as required according to standard trypsinization procedures [14] .
Calcein AM assay: Cell line suspensions containing about 1.0  10 5 cells/mL were placed in 96-well microtiter plates and after 24 h stabilization (time zero), test compounds, which were serially diluted in DMSO, were added (4 x 20 µL aliquots). Control cultures were treated with DMSO alone, such that the final DMSO concentration in the incubation mixtures never exceeded 0.6%. Test compounds were typically evaluated at six 3-fold dilutions and the highest final concentration was generally 50 µM. After 72 h incubation, 100 µL of 2 µM Calcein AM solution (Molecular Probes, Invitrogen, CA, USA) was added and incubation was continued for a further hour. The fluorescence of viable cells was then quantified using a Fluoroskan Ascent instrument (Labsystems, Finland). The percentage of surviving cells in each well was calculated by dividing the intensity of the fluorescence signals from the exposed wells by the intensity of signals from control wells and multiplying by 100. These ratios were then used to construct doseresponse curves from which IC 50 values were calculated. Staurosporine (Sigma-Aldrich, UK) and galanthamine (Teva Czech Industries, Opava, Czech Republic) were used as positive and negative controls, respectively.
